GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nanosonics Ltd (OTCPK:NNCSF) » Definitions » Days Sales Outstanding

Nanosonics (Nanosonics) Days Sales Outstanding : 80.34 (As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Nanosonics Days Sales Outstanding?

Nanosonics's average Accounts Receivable for the six months ended in Dec. 2023 was $23.5 Mil. Nanosonics's Revenue for the six months ended in Dec. 2023 was $53.3 Mil. Hence, Nanosonics's Days Sales Outstanding for the six months ended in Dec. 2023 was 80.34.

The historical rank and industry rank for Nanosonics's Days Sales Outstanding or its related term are showing as below:

NNCSF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 41.35   Med: 65.87   Max: 79.06
Current: 76.86

During the past 13 years, Nanosonics's highest Days Sales Outstanding was 79.06. The lowest was 41.35. And the median was 65.87.

NNCSF's Days Sales Outstanding is ranked worse than
63.67% of 812 companies
in the Medical Devices & Instruments industry
Industry Median: 64.88 vs NNCSF: 76.86

Nanosonics's Days Sales Outstanding increased from Dec. 2022 (67.00) to Dec. 2023 (80.34).

Nanosonics Days Sales Outstanding Historical Data

The historical data trend for Nanosonics's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanosonics Days Sales Outstanding Chart

Nanosonics Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 57.70 63.27 75.16 82.34 69.93

Nanosonics Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 91.24 83.03 67.00 78.07 80.34

Competitive Comparison of Nanosonics's Days Sales Outstanding

For the Medical Instruments & Supplies subindustry, Nanosonics's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nanosonics's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nanosonics's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Nanosonics's Days Sales Outstanding falls into.


Nanosonics Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Nanosonics's Days Sales Outstanding for the fiscal year that ended in Jun. 2023 is calculated as

Days Sales Outstanding (A: Jun. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2022 ) + Accounts Receivable (A: Jun. 2023 )) / count ) / Revenue (A: Jun. 2023 )*Days in Period
=( (17.068 + 26.009) / 2 ) / 112.426*365
=21.5385 / 112.426*365
=69.93

Nanosonics's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (26.009 + 20.922) / 2 ) / 53.305*365 / 2
=23.4655 / 53.305*365 / 2
=80.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nanosonics  (OTCPK:NNCSF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Nanosonics Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Nanosonics's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanosonics (Nanosonics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nanosonics Ltd (OTCPK:NNCSF) » Definitions » Days Sales Outstanding
Comparable Companies
ASX:TRJ ASX:SDI ASX:AHC ASX:OSX ASX:ANN ISRG XPAR:EL BDX TSE:7741 XSWX:ALC RMD OCSE:COLO B WST TSE:4543 XSWX:STMN XPAR:DIM BAX HOLX COO TSE:7733
Traded in Other Exchanges
OQS:Germany NAN:Australia
Address
7-11 Talavera Road, Level 1 Building A, Macquarie Park, Sydney, NSW, AUS, 2113
Website
https://www.nanosonics.com.au
Nanosonics is a single-product firm and its trophon device provides high-level disinfection of ultrasound probes used in semicritical procedures. The patented technology uses low temperature sonically activated hydrogen peroxide mist that is suitable for probes sensitive to damage. Automated HLD is increasingly being used as the standard of care globally as it is superior in preventing cross-infection across patients. Nanosonics' revenue is made up of capital sales of trophon units, ongoing consumables sales, and service revenue. At June 2022, there were 29,850 trophon units installed globally. Market penetration rates range from over 75% in Australia and New Zealand, roughly 44% in the U.S. to low-single-digit penetration in Europe, Middle East, and Africa, and elsewhere in Asia-Pacific.